Sitagliptin Orion
Sitagliptin Orion helps lower blood sugar levels in adults with type 2 diabetes.
Form
tabletti, kalvopäällysteinen
Strength
50 mg
Active Ingredient
Sitagliptin hydrochloride monohydrate
Manufacturer
Orion Corporation
How to Use
Dosage
One 100 mg tablet once a day.
Method
Take the tablet by mouth, with or without food.
Important
Do not take more than one 100 mg tablet per day, unless your doctor tells you otherwise.
Possible Side Effects
COMMON
- •Low blood sugar
- •Nausea
- •Flatulence (gas)
- •Vomiting
- •Constipation
- •Swelling of hands or feet
- •Flu-like symptoms
- •Headache
- •Upper respiratory infection
- •Blocked or runny nose and sore throat
- •Osteoarthritis
- •Pain in arms and legs
RARE
- •Stomach pain
- •Diarrhea
- •Drowsiness
- •Dry mouth
- •Dizziness
- •Itching
- •Reduced number of platelets
- •Kidney problems (sometimes requiring dialysis)
- •Joint pain
- •Muscle pain
- •Back pain
- •Lung disease (interstitial)
- •Blistering skin condition (pemphigoid)
Important Warnings
- Sitagliptin Orion can cause inflammation of the pancreas (pancreatitis). Tell your doctor if you have had pancreatitis before.
- If you get blisters on your skin, stop taking the medicine and tell your doctor. These could be a sign of a skin condition called bullous pemphigoid.
- Do not take this medicine if you are allergic to sitagliptin or any other ingredient.
- Tell your doctor if you have had gallstones, alcohol dependence, or very high levels of triglycerides (a type of fat) in your blood, as these can increase the risk of pancreatitis.
- Children and adolescents under 18 years of age should not use this medicine.
Show 2 more warnings
- Do not use this medicine if you are pregnant, breastfeeding, or planning to become pregnant or breastfeed.
- STOP taking Sitagliptin Orion and contact a doctor right away if you get severe, continuous stomach pain with nausea or vomiting. These could be signs of pancreatitis.
Use in Elderly Patients
Category C
Suitable for older adults, with specific precautions. Reduce the dose in moderately severe renal impairment. (updated 10.6.2024)